Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Guidelines concerning the definition of failure of therapies used to reduce the risk of fracture are provided.This study aims to provide guidelines concerning the definition of failure of therapies used to reduce the risk of fracture.A working group of the Committee of Scientific Advisors of the International Osteoporosis Foundation was convened to define outcome variables that may assist clinicians in decision making.In the face of limited evidence, failure of treatment may be inferred when two or more incident fractures have occurred during treatment, when serial measurements of bone remodelling markers are not suppressed by anti-resorptive therapy and where bone mineral density continues to decrease.The provision of pragmatic criteria to define failure to respond to treatment provides an unmet clinical need and may stimulate research into an important issue.

Original publication

DOI

10.1007/s00198-012-2093-8

Type

Journal article

Journal

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Publication Date

12/2012

Volume

23

Pages

2769 - 2774

Addresses

Department of Internal Medicine and Infectious Diseases, Hospital del Mar-IMIM, Autonomous University of Barcelona, RETICEF, Instituto Carlos III, P. Maritim 25-29, 08003 Barcelona, Spain. adiez@parcdesalutmar.cat

Keywords

IOF CSA Inadequate Responders Working Group, Humans, Osteoporosis, Treatment Outcome, Treatment Failure, Bone Remodeling, Bone Density, Bone Density Conservation Agents, Osteoporotic Fractures, Biomarkers